Literature DB >> 27668054

Lonsurf (Trifluridine plus Tipiracil): A New Oral Treatment Approved for Patients with Metastatic Colorectal Cancer.

Lisa A Raedler.   

Abstract

Entities:  

Year:  2016        PMID： 27668054      PMCID： PMC5013844     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  2 in total

1.  Projections of the costs associated with colorectal cancer care in the United States, 2000-2020.

Authors:  K Robin Yabroff; Angela B Mariotto; Eric Feuer; Martin L Brown
Journal:  Health Econ       Date:  2008-08       Impact factor: 3.046

2.  Randomized trial of TAS-102 for refractory metastatic colorectal cancer.

Authors:  Robert J Mayer; Eric Van Cutsem; Alfredo Falcone; Takayuki Yoshino; Rocio Garcia-Carbonero; Nobuyuki Mizunuma; Kentaro Yamazaki; Yasuhiro Shimada; Josep Tabernero; Yoshito Komatsu; Alberto Sobrero; Eveline Boucher; Marc Peeters; Ben Tran; Heinz-Josef Lenz; Alberto Zaniboni; Howard Hochster; James M Cleary; Hans Prenen; Fabio Benedetti; Hirokazu Mizuguchi; Lukas Makris; Masanobu Ito; Atsushi Ohtsu
Journal:  N Engl J Med       Date:  2015-05-14       Impact factor: 91.245
  2 in total
  2 in total

1.  Morphological Profiling Identifies a Common Mode of Action for Small Molecules with Different Targets.

Authors:  Tabea Schneidewind; Alexandra Brause; Axel Pahl; Annina Burhop; Tom Mejuch; Sonja Sievers; Herbert Waldmann; Slava Ziegler
Journal:  Chembiochem       Date:  2020-07-24       Impact factor: 3.164

2.  Polycyclic nitrogen heterocycles as potential thymidine phosphorylase inhibitors: synthesis, biological evaluation, and molecular docking study.

Authors:  Karen Aknin; Alexis Bontemps; Amaury Farce; Eric Merlet; Philippe Belmont; Philippe Helissey; Philippe Chavatte; Marie-Agnès Sari; Sylviane Giorgi-Renault; Stéphanie Desbène-Finck
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.